Compounders Research Compare

electroCore, Inc.(ECOR)

Medical - Devices · Rockaway, NJ

$9.97-0.16 (-1.58%)

Delayed quote: Oct 6, 2026, 2:29 PM EDT

About electroCore, Inc.

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Rockaway, NJ

83 employees

www.electrocore.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joshua Lev

View full financials

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T18:31:14.572Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:31:14.572Z.

Quote observation: 2026-10-06T18:29:23.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 89,888,373
Total debt · period ending 2026-06-30: 9,563,000
Cash · period ending 2026-06-30: 8,501,000
TTM operating EBITDA · period ending 2026-06-30: -12,511,000

FMP input reference: 4f3bc52aaee10dc4864d073eee8720ed85d0d11e7a3d16422bde167dd05b99a5

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ECOR EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

ECOR Competitors' EV/EBITDA Ratio

electroCore, Inc.

Current

Market Cap

$89.89M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PMV Pharmaceuticals, Inc.

Market Cap

$89.86M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ImmuCell Corporation

Market Cap

$88.21M

EV/EBITDA Ratio

14.69x

TTM Avg

15.77x

3Y Avg

20.95x

5Y Avg

32.73x

Rallybio Corporation

Market Cap

$90.24M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CareCloud, Inc.

Market Cap

$89.02M

EV/EBITDA Ratio

4.71x

TTM Avg

4.46x

3Y Avg

3.36x

5Y Avg

3.41x

Neumora Therapeutics, Inc. Common Stock

Market Cap

$88.95M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Equillium, Inc.

Market Cap

$91.36M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Biomea Fusion, Inc.

Market Cap

$91.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Park Dental Partners, Inc. Common Stock

Market Cap

$92.47M

EV/EBITDA Ratio

N/A

TTM Avg

51.11x

3Y Avg

51.11x

5Y Avg

51.11x

Conexeu Sciences Inc.

Market Cap

$92.85M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
electroCore, Inc. (ECOR)	$89.89M	N/A	N/A	N/A	N/A
PMV Pharmaceuticals, Inc. (PMVP)vs ›	$89.86M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$88.21M	14.69x	15.77x	20.95x	32.73x
Rallybio Corporation (RLYB)vs ›	$90.24M	N/A	N/A	N/A	N/A
CareCloud, Inc. (CCLD)vs ›	$89.02M	4.71x	4.46x	3.36x	3.41x
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$88.95M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$91.36M	N/A	N/A	N/A	N/A
Biomea Fusion, Inc. (BMEA)vs ›	$91.46M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.47M	N/A	51.11x	51.11x	51.11x
Conexeu Sciences Inc. (CNXU)vs ›	$92.85M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics